Nerissa C. Kreher MD, MS, MBA

Dr. Nerissa Kreher is an accomplished physician executive and pediatric endocrinologist with more than a decade of biotech experience in Clinical Development and Medical Affairs. She has held leadership roles in both private, start-up biotechnology and public, large biotech companies. Her expertise is in the development of products for rare diseases spanning multiple therapeutic areas.

Nerissa has led the design and execution of multiple global rare disease clinical development programs, including ex vivo gene therapy programs for Fabry and Gaucher disease as well as others, including a program for retinopathy of prematurity. In addition, she has overseen the medical affairs build out for companies including Zafgen and Enobia (acquired by Alexion).

Nerissa holds multiple degrees, including an Executive MBA from Northeastern University, an MD from East Carolina University School of Medicine and an MS in Clinical Research from Indiana University. She is certified in Pediatric Endocrinology by the American Board of Pediatrics.